CompletedNCT02473250
Predicting Antidepressant Response in Bipolarity With PET Imaging
About this title
Read the official source — NCT02473250Medication studyAges 18–60United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 40
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT02473250
- Official title
Show the full official title
Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Fluoxetine and Citalopram.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
